---
audienceLevel: patient
cancerTypes:
- general
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Drugs Approved for Multicentric Castleman Disease - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/multicentric-castleman-disease
version: v1
---

# Drugs Approved for Multicentric Castleman Disease - NCI

# Drugs Approved for Multicentric Castleman Disease

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for multicentric Castleman disease. The list includes generic names and brand names. The drug names link to NCIâ€™s Cancer Drug Information summaries. There may be drugs used in multicentric Castleman disease that are not listed here.

## Drugs Approved for Multicentric Castleman Disease

- [Siltuximab](/about-cancer/treatment/drugs/siltuximab)
- [Sylvant (Siltuximab)](/about-cancer/treatment/drugs/siltuximab)
